State of Distressed: Jennifer Selendy on LME Battles, Antitrust

Bloomberg Intelligence's podcast features Jennifer Selendy discussing recent legal challenges to creditor cooperation agreements in liability-management cases involving Altice and Selecta, arguing skepticism that a single issuer's debt instrument constitutes a separate product market for antitrust purposes. The conversation also revisits early LME litigation, the Incora dispute, and in‑court surprises, while BI hosts outline their 2026 outlook and touch on recent developments at Hertz, First Brands, Ardagh Group and Azul — items of legal and restructuring interest but without immediate market-moving financial metrics.

Analysis

Market structure: Antitrust challenges to creditor cooperation and LME-era litigation increase transaction costs and fragmentation in liability-management markets, directly benefiting litigation/claims purchasers, distressed-debt funds, and law firms while hurting large coordinators (lead arrangers, special-situations desks) that rely on streamlined exchange offers. Expect incremental illiquidity: high-yield bond spreads could reprice wider by 50–200bp across stressed credits over 1–6 months as consensual restructurings become harder and haircuts/dispute risk rise.

Risk assessment: Tail risks include a court ruling that invalidates common creditor coordination tools or a precedent that treats individual debt instruments as product markets, which could force more contested restructurings and lift default rates by +1–3ppt in fragile cohorts over 12–24 months. Near-term (days–weeks) volatility will cluster around court filings and rulings; medium-term (3–9 months) credit dispersion and recovery uncertainty will rise; long-term (1–3 years) documentation and market practice may reconfigure, increasing legal costs and lengthening reorganizations.

Trade implications: Tactical hedge: reduce unsecured HY beta and increase secured, floating-rate exposure; expect relative outperformance for senior secured loans vs unsecured HY by 100–300bp in stressed cycles. Options/derivative plays: buy 3–6 month protection (CDS or HYG puts) sized 1–2% of NAV to hedge idiosyncratic legal rulings; consider long positions in distressed-debt managers and specialty litigation finance where returns compress less.

Contrarian angles: Consensus assumes wholesale breakdown of liability management; that overstates risk — courts may narrow rulings to specific clauses, creating standardized safer playbooks that restore some LM utility within 6–18 months. Historical parallels (post-2008 creditor litigation) show initial spread shock followed by renewed primary-market adaptation; a targeted, conviction-weighted approach (long secured loans, selective CDS shorts) captures mispricings while avoiding blanket directional bets.

Key Decisions for Investors

• Reduce unsecured high-yield ETF exposure (HYG, JNK) by 2–4% of portfolio within 2 weeks and redeploy proceeds into senior secured loan ETF BKLN (target 2–4% long) to capture floating-rate, senior protection against protracted restructurings.
• Purchase 1–2% of NAV notional CDS protection on CDX HY (next series) or buy 3–6 month HYG puts (2.5%–5% OTM) as an event hedge against a 100–300bp spread widening triggered by adverse antitrust rulings; reassess after 90 days.
• Initiate selective long positions (1–2% each) in publicly listed distressed-debt managers and litigation finance proxies (e.g., specialist asset managers; use tickers with >$500m AUM) with 12–24 month horizon to benefit from higher realized spreads and fee capture.
• Establish a pair trade: long BKLN (2% notional) / short HYG (2% notional) to express expected outperformance of secured loans vs unsecured high yield over next 3–9 months; trim if unsecured spreads compress by >100bp from current levels.
• Monitor specific legal catalysts: watch Altice, Selecta, and LME case filings and any DOJ/FTC commentary over the next 30–90 days; if courts limit antitrust exposure to LM docs, reallocate 50–75% of hedges back to HY within 60–120 days.